Feb 62020 From mushrooms to ecstasy, a renaissance in psychedelics research MDMA and psilocybin have been granted breakthrough therapy status by the FDA, signaling a shift in the future of mental health treatment. Clinical studies are underway. How we treat them moving forward matters.